PS05-085, Surv of HIV/AIDS Related Events Among Persons Not Receiving Care

监测未接受治疗者中与艾滋病毒/艾滋病有关的事件项目是一个补充项目， 监测活动将收集关于未接受治疗的艾滋病毒感染者的数据。的 收集的数据将提供有关当地护理需求、接受护理的障碍以及当地 支助服务.这些信息对于向包括纽约在内的地方规划团体提供信息至关重要。 城市规划理事会，负责确定RyanWhite CARE的适当分配 行动基金。所收集的信息还将有助于地方对侧重于与以下方面联系的方案进行评估： 在乎 监测未接受治疗者中与艾滋病毒/艾滋病有关的事件项目的目标是， 建立艾滋病毒/艾滋病补充监测系统，以查明艾滋病毒确诊者 感染和没有得到照顾的人。具体而言，与疾病预防控制中心合作，NYC DOHMH将： 查明居住在纽约市的被诊断为艾滋病毒感染者，但没有接受治疗的人。 通过患者访谈确定接受护理的障碍。 确定被诊断为艾滋病毒感染但未接受治疗的人的临床状况 护理，以估计当这些人与护理联系在一起时所需的额外资源。 这些目标将通过寻找和招募得不到护理的艾滋病毒感染者来实现。后 已获得同意的合格参与者将由经过培训的 面试人员。还将采集血液标本用于进一步的实验室检查，包括CD 4计数， HIV病毒载量和耐药性检测。

The Surveillance of HIV/AIDS Related Events Among Persons Not Receiving Care project is a supplemental surveillance activity that will collect data about persons infected with HIV who are not receiving care. The data to be collected will provide information on the local need for care, barriers to receiving care, and local support services. This information will be critical for informing local planning groups, including the New York City Planning Council, who is responsible for the determining the appropriate allocation of RyanWhite CARE Act funds. The information gathered will also benefit local evaluation of programs focusing on linkage to care. The goal of the Surveillance of HIV/AIDS Related Events Among Persons Not Receiving Care project is to develop a supplemental HIV/AID surveillance system to identify persons who have a diagnosis of HIV infection and who are not receiving care. Specifically, in collaboration with the CDC, NYC DOHMH will: Identify persons residing in New York City who have a diagnosis of HIV, but who are not receiving care. Ascertain barriers to receiving care through a patient interview. Determine the clinical status of persons who have a diagnosis of HIV infection, but who are not receiving care, to estimate the added resources that would be required when these individuals are linked to care. These goals will be accomplished by locating and recruiting HIV-infected persons not receiving care. After consent has been obtained eligible participants will be administered a standardized questionnaire by trained interview staff. Blood specimens will also be collected for further laboratory testing to include CD4count, HIV viral load, and resistance testing.